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Blood group H antigen with globe-series tructure, reacting with the monoclonal antibody MBrl, was iso- 
lated and characterized from human blood group 0 erythrocytes. The structure was identified by methyla- 
tion analysis, direct probe mass spectrometry, and ‘H-nuclear magnetic resonance spectroscopy as shown 
below: Fucal + 2Gal/?l+ 3GalNAcjYl+ 3Galal+4Galj?l -rrlGlc/Il + 1Cer 
Blood group H antigen 
1. INTRODUCTION 
Blood group ABH determinants in human 
erythrocytes are carried by type 2 chain in either 
glycolipids or glycoproteins [l]. Recently, a series 
of extended globo-series glycolipids has been 
isolated and characterized from human teratocar- 
cinema 2102. Among these, a new type of blood 
group .H antigen with globo-series structure was 
characterized and designated ‘Gl-6’ [2]. In human 
adult cells and tissues, the presence of extended 
globo-series structures has been unknown, except 
for the presence of a small quantity of Forssman 
glycolipid in tissues of some human populations 
(Fs+ group) and in some human cancers [3], and 
the presence of ‘para-Forssman’ glycolipid in 
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human erythrocytes [4]. Recently, a monoclonal 
antibody (MBrl) directed to breast cancer and nor- 
mal mammary gland epithelia was shown to react 
specifically with ‘GL-6’, the globo-series H antigen 
[5]. During a systematic fractionation of blood 
group active glycolipids in human erythrocyte 
membranes, we noticed the presence of a blood 
group H glycolipid with globo-series structure 
(hereby designated ‘globo-H’) reacting with an- 
tibody MBrl. We report the isolation and 
characterization of this new type of blood group H 
antigen from human erythrocytes. 
2. MATERIALS AND METHODS 
Human erythrocyte membranes were extracted 
with isopropanol-hexane-water (55 : 25 : 20, lower 
phase) and the upper neutral glycolipid fraction 
was prepared from the total extract as previously 
described [6]. The fraction containing x-series 
glycolipids (x1-x1, eluted between Hi and HZ) [7] 
was prepared by low-pressure HPLC on 
Iatrobeads 6RS-8060 column, and this fraction 
was rechromatographed on 6RS-8010 column with 
high-pressure HPLC according to the method 
originally described in [8] and modified subse- 
quently [6]. The x3 glycolipid fraction (fig. 1) eluted 
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Fig.1. Separation pattern of x-series glycolipids of 
human blood group 0 erythrocytes. Separation was 
performed on Iatrobeads 6RS-8010 column in an 
isopropanol-hexane-water gradient of 55 : 40 : 5 to 
55 :30: 15. The original sample applied to the column 
was the fraction containing x-series glycolipids eluted 
from the first low-pressure chromatography as 
previously described [7]. HPTLC was developed in 
chloroform-methanol-water (65 : 35 : 8). 
between tube number 38-48 was pooled and 
acetylated in pyridine-acetic anhydride (2 : l), and 
further purified on HPTLC plates developed in a 
solvent mixture of 1,2-dichloroethane-acetone- 
water (60:40:0.1). Acetylated derivatives of Gbr, 
globoside, Gg,+, and nLcs were run as controls. 
Among a few components of theacetylated x3 frac- 
tion, the fastest migrating component, which 
migrated between acetylated globoside and acetyl- 
ated Gbs, was scraped and extracted with chloro- 
form-methanol (2 : 1). Glycolipid acetates 
separated on HPTLC were revealed by ultraviolet 
light after spraying with 0.02% Prim&n (Aldrich, 
Milwaukee, WI) in acetone-water (2: 1) [9]. The 
yield of glycolipid was - 100 fig from 2 1 packed 
erythrocytes. The monoclonal antibody MBrl [lo] 
was a gift from Dr S. Sonnino (Universita Degli 
Studi Di Milano, Italy). The antibody was selected 
by its specific reactivity to breast cancer, and its 
epitope structure was identified as globo-H [5]. 
Immunostaining of glycolipid was performed ac- 
cording to the procedure of [l 11. Methyl&ion 
analysis and direct-probe mass spectrometry were 
performed as previously described [2,6,7]. Proton 
NMR spectra were obtained on a Bruker WM-500 
spectrometer operating in the Fourier-transform 
mode and using quadrature detection. A glycolipid 
sample (1OO~g) was deuterium+exchanged and 
spectra were taken in 0.4 ml MeSOds containing 
2% DzO and 1% tetramethylsilane as a chemical 
shift reference. The procedure is essentially the 
same as previously described [12]. 
3. RESULTS 
A series of glycolipids eluted from the 
Iatrobeads column between Hr and Hz glycolipids 
were called xi, x2, x3, and xg, according to the se- 
quence of elution as shown in fig.1. Two com- 
ponents in the x3 fraction, xra and xgb, and the x2 
glycolipid were clearly separated on HPTLC as 
acetates. The fast-migrating component with a 
mobility between acetylated Gbs and acetylated 
Gg4 (xaa, fig.2, lane 1, panel A) and the compo- 
nent with the slowest mobility (xsb, fig.2, lane 3, 
panel A) were clearly separated to homogeneity. 
The acetylated x2 glycolipid migrated as an in- 
termediate (fig.2, lane 2, panel A) was identified as 
having the structure GalNA@l - 3Gal,&l- 
4GlcNAc#l-3G~1-4GIqt5’1-1Cer, in 
agreement with previous studies [7]. The xsb 
A 
x31 
Fig.2. HPTLC pattern of purified xsa (globe-H) 
glycolipid. Panel A: Purified glycolipid acetates. Lane 1, 
xsa; lane 2, x2; lane 3, xsb. The position of acetylated 
derivatives of each glycolipid is indicated in the left 
margin. Solvent, see text. Stained by orcinol-sulfuric 
acid. Panel B: lane 1, upper neutral glycolipid of blood 
group 0 erythrocytes; lane 2, purified deacetylated xsa 
glycolipid (globe-H antigen). Left margin indicates the 
position of characterized glycolipids (1,6,7). Note that x3 
component is very minor. Panel C: HPTLC of upper 
neutral glycolipids of 0 erythrocytes stained by 
orcinol-sulfuric acid (lane 1) and its immunostaining 
pattern by MBrl antibody (lane 2). HPTLC in panels B 
and C developed with chloroform-methanol-water 
(60:35:8). 
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glycolipid was identified as having the structure 
GalNAc+Yl - 3GalNAMl - 3GaLul - 
4Ga4Yl-4GlCpl- ICer, which is identical to 
that previously described [4] and termed ‘para- 
Forssman’. Since the structures of these glycolipids 
have been previously elaborated, the supporting 
data for each structure are not presented here. The 
x3a glycolipid, after deacetylation, was 
homogeneous (fig.2, lane 2, panel B) and was 
stained by the monoclonal antibody MBrl (fig.2, 
lane 2, panel C). This antibody was recently iden- 
tified as being directed to globo-series H anti- 
gen (Fuccu1-2Ga491-3GalNAc,dl-3GaLYl 
Fig.3. Gas chromatography-mass pectrometry of 
partially 0-methylated hexitol and hexosaminitol 
acetates of xpa glycolipid. Separation performed on 
capillary column DB-5 in panel A and on OV-225 in 
panel B. Peaks are identified as indicated. 
-4GaI&-4Glt.$l- 1Cer) [5]. 
On methylation analysis, the purified xsa 
glycolipid gave 2,3,4-tri-O-Me-Fuc, 2,3,6-tri-O- 
Me-Gal, 2,3,6-tri-O-Me-Glc, and 4,6-d&O-Me- 
GalNAcMe (fig.3A). 3,4,6-Tri-O-Me-Gal was 
separated from 2,4,6-tri-O-Me-Gal under different 
conditions of gas chromatography (capillary col- 
umn 0V225) (fig.3B). On direct probe mass spec- 
trometry, the following fragments were detected: 
m/z 189 - 157, 228 (hut not 260), 393 - 361, 
638 - 606, and 843 - 811 (see fig.4). These 
fragments agree very well with the sequence in- 
dicated in the insert to fig.4. The absence of a frag- 
ment at m/z 182 and the presence of the fragment 
at m/z 228 indicate a preferential loss of 
Deoxyhex-O-Hex-OH from the 3 position of the 
internal HexNAc. 
The NMR spectrum of this glycolipid showed a 
characteristic pattern for globo-series H (fig.5) as 
previously reported [2]. However, resonances for 
the anomeric protons of the penultimate Gal (V-l 
in fig.5) and GalNAc (IV-l in fig.5) residues were 
separated at 308 K, although they were not 
separated in a previous study at 303 K [2]. The 
triplet at 4104 ppm (308 K) was assigned as H-5 of 
~-Gal residue (III-5 in fig.5) based on the rationale 
as previously described [2]. The quartet at 
4076 ppm (308 K) was assigned as H-5 of ~Fuc 
(IV-5 in fig.5) by decoupling from the Fuc methyl 
doublet (IV-6) at 1087 ppm (J = 6.1 Hz). The 
assignments for II-4 and III-4 (fig.5) were made 
tentatively on the basis of comparison with the 
data of [12] for globoside and Forssman antigen. 
Details of the assignment of each resonance in 
NMR spectra of extended globo-series glycolipids 
will be published elsewhere. 
Fig.4. Direct probe mass spectrometry of permethylated x3a glycolipids in Finnigan 3700 mass spectrometer with 6100 
data system under the following conditions: electron energy, 35 V; ion energy programmed from + 5.5 V; extractor, 
+7.7 V; lens, 30 V; emission, +O.S mA; electron multiplier, 2200 V; and sensitivity, 10-7 AN. 
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Fig.5 Proton NMR spectrum of x3a glycolipid. 1OOpg 
of glycolipid with 2000 scans. Probe temperature was 
308 K. Sugar esidues are indicated by roman numerals 
and positions of protons are indicated by arabic 
numbers. For assignment of resonances for each proton, 
see text. 
4. DISCUSSION ACKNOWLEDGEMENTS 
Extended globo-series glycolipids have been 
found as major components of human teratocar- 
cinema [2] and human breast cancer [f]; however, 
their presence has not been chemically established 
in human adult tissues, except for a small quantity 
of Forssman and ‘para-Forssman’ glycolipids 
[3,4]. The monoclonal antibody MBrl, which is 
directed to a human breast cancer cell line, defines 
a glycolipid with the structure identical to ‘GL-6’, 
previously isolated from human teratocarcinoma 
[5]. The antigen has now been isolated from 
human blood group 0 erythrocytes as one of the x- 
series glycolipids (xsa component) eluted between 
Hr and HZ. The method of isolation described here 
is typical for purification of minor components 
present in a mixture of glycolipids, i.e., two steps 
of HPLC on Iatrobeads, separation of acetylated 
fraction on HPTLC, isolation of a single compo- 
nent, followed by deacetylation. The TLC migra- 
tion of acetylated glycolipids often shows unusual 
mobility. The globo-series H antigen is a ceramide 
hexasaccharide, but its acetylated derivative 
showed a much faster TLC mobility than 
acetylated ceramide tetrasaccharide (acetylated 
globoside and acetylated asialo GMr). Methylation 
analysis, direct probe mass spectrometry, and 
NMR spectrometry unambiguously indicate that 
the purified glycolipid has the structure shown 
below: 
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Fuccu1-2Gal,81-3GalNAc,81-3Galc~1- 
4Gal@l-4Gl@l- 1 Cer 
Two ceramide pentasaccharides showing a much 
slower mobility than globe-H antigen as acetylated 
derivatives were isolated, one of which was iden- 
tified as x2 glycolipid (GalNAc#l -3G481- 
4G1cNAc#1-30~1-4G1~91-1Cer) and 
the other as ‘para-Forssman’ (GalNAc,&l- 
3GalNAc$1-3Gah~l-4Gal8l-4Glc#1 
-1Cer). As free compounds, the globo-H an- 
tigen and these glycolipids are hardly separated on 
HPTLC. 
This is the first clear chemical demonstration of 
the existence of globe-series H antigen in normal 
adult human cells. The possible presence of blood 
group A or B analogues with globo-series tructure 
is anticipated and is under investigation. 
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